Molbio Diagnostics Limited IPO — Subscription & GMP
- Price band
- ₹768 – ₹807
- Lot size
- 18
- Issue size
- ₹658.39 Cr
- Bidding
- 10 Aug 2026 → 12 Aug 2026
- Allotment
- 13 Aug 2026
- Listing
- 17 Aug 2026
Listing outcome
Official exchange pricesGMP was out by 6.3 percentage points in the buyer’s favour — it implied +15.12% and the issue listed +21.44%. Counted in our running GMP accuracy record.
Schedule
- 10 Aug 2026IPO open date
- 12 Aug 2026IPO close date
- 13 Aug 2026Allotment date
- 14 Aug 2026Funds unblock or debit
- 17 Aug 2026Tentative listing date
Fundamentals
The business, its valuation and returnsMolbio Diagnostics Limited operates as an innovative global point-of-care (POC) molecular diagnostics company, providing rapid, decentralized testing solutions for infectious and non-communicable diseases to public health programs, hospitals, and diagnostic laboratories.
Its flagship product is the Truenat platform—a portable, battery-operated real-time PCR system recognized by the WHO and deployed in over 85 countries—complemented by a strategically expanding portfolio in portable radiology, digital pathology, and breast cancer screening. The company leverages a highly profitable recurring revenue model: after the initial sale of a Truenat device, it generates continuous, long-term income from the proprietary disposable test kits, microchips, and reagents required to run every test. This recurring demand is the financial backbone of the business, with consumable test kits contributing nearly 74% of its operating revenue in FY26. By designing its testing chips to work exclusively with its own platforms and operating in a market with high entry barriers requiring years of R&D, Molbio ensures strong customer lock-in and sustainable growth.
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS | ₹14.77 | — |
| P/E ratio | 54.64× | — |
Promoter holding pre/post issue is in the offer document but we do not yet extract it. Left blank rather than estimated.
Read from the company’s offer document filed with SEBI. Figures are the latest reported financial year, as restated in that filing.
Figures are as reported and not independently audited, and are read 7 d ago.
Grey market premium
Unofficial · not from any exchangeSubscription status
Live from NSE · fetched 4 hr ago| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| 1Qualified Institutional Buyers(QIBs) | 23.25 L | 25.26 Cr | 108.63× |
| 1(a)Foreign Institutional Investors(FIIs) | — | 8.13 Cr | — |
| 1(b)Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies) | — | 15.06 Cr | — |
| 1(c)Mutual funds | — | 1.24 L | — |
| 1(d)Others | — | 2.06 Cr | — |
| 2Non Institutional Investors | 17.44 L | 6.16 Cr | 35.35× |
| 2.1Non Institutional Investors(Bid amount of more than Ten Lakh Rupees) | 11.63 L | 4.25 Cr | 36.52× |
| 2.1(a)Corporates | — | 5.29 L | — |
| 2.1(b)Individuals(Other than RIIs) | — | 4.02 Cr | — |
| 2.2Non Institutional Investors(Bid amount of more than Two Lakh Rupees upto Ten Lakh Rupees) | 5.81 L | 1.92 Cr | 33.01× |
| 3Retail Individual Investors(RIIs) | 40.69 L | 3.69 Cr | 9.08× |
| 3(a)Cut Off | — | 3.13 Cr | — |
| 3(b)Price bids | — | 56.15 L | — |
| 4Employees | 20,519 | 2.21 L | 10.76× |
| 4(b)Price Bids | — | 48,960 | — |
| Total | 81.59 L | 35.14 Cr | 43.07× |
Source: NSE issue information · BSE public issue
Demand curve
Shares bid at each price point · BSE₹768 → ₹807 · peak 57.36 Cr shares bid
Anchor investors
From NSE's anchor allocation filingAnchor investors are institutions allotted shares one working day before public bidding opens, in exchange for a lock-in. Up to 60% of the QIB portion can go to them, which reduces the QIB shares left for everyone else — and their participation is widely read as a confidence signal.
| # | Anchor investor | Shares | % of anchor | Amount |
|---|---|---|---|---|
| 1 | HDFC MUTUAL FUND - HDFC PHARMA AND HEALTHCARE FUND | 1.38 L | 3.96% | ₹11.14 Cr |
| 2 | HDFC VALUE FUND | 1.08 L | 3.11% | ₹8.75 Cr |
| 3 | HDFC MUTUAL FUND - HDFC INNOVATION FUND | 1.08 L | 3.11% | ₹8.75 Cr |
| 4 | HDFC MUTUAL FUND - HDFC MNC FUND | 78,858 | 2.26% | ₹6.36 Cr |
| 5 | KOTAK CONTRA FUND | 1.45 L | 4.15% | ₹11.67 Cr |
| 6 | KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK HEALTHCARE FUND | 1.45 L | 4.15% | ₹11.67 Cr |
| 7 | KOTAK MAHINDRA TRUSTEE CO LTD A/C KOTAK CONSUMPTION FUND | 1.45 L | 4.14% | ₹11.67 Cr |
| 8 | ICICI PRUDENTIAL QUALITY FUND | 1.86 L | 5.33% | ₹15.00 Cr |
| 9 | ISIF EQUITY LONG-SHORT FUND | 37,170 | 1.07% | ₹3.00 Cr |
| 10 | ICICI PRUDENTIAL EXPORTS AND SERVICES FUND | 1.49 L | 4.26% | ₹12.00 Cr |
| 11 | NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND RCT-RPF | 2.48 L | 7.11% | ₹20.00 Cr |
| 12 | NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA INNOVATION FUND | 1.24 L | 3.55% | ₹10.00 Cr |
| 13 | GOLDMAN SACHS FUNDS - GOLDMAN SACHS INDIA EQUITY PORTFOLIO | 3.10 L | 8.88% | ₹25.00 Cr |
| 14 | GOLDMAN SACHS ETF TRUST - GOLDMAN SACHS INDIA EQUITY ETF | 61,974 | 1.78% | ₹5.00 Cr |
| 15 | INTERNATIONAL FINANCE CORPORATION* | 2.48 L | 7.11% | ₹20.00 Cr |
| 16 | BLACKROCK GLOBAL FUNDS - INDIA FUND | 2.48 L | 7.11% | ₹20.00 Cr |
| 17 | MIRAE ASSET HEALTHCARE FUND MIRAHCFD | 2.48 L | 7.11% | ₹20.00 Cr |
| 18 | WHITEOAK CAPITAL PHARMA AND HEALTHCARE FUND | 80,568 | 2.31% | ₹6.50 Cr |
| 19 | WHITEOAK CAPITAL AGGRESSIVE HYBRID FUND | 43,362 | 1.24% | ₹3.50 Cr |
| 20 | MOTILAL OSWAL LARGE CAP FUND | 1.24 L | 3.55% | ₹10.00 Cr |
| 21 | TATA INDIA PHARMA & HEALTHCARE FUND | 1.24 L | 3.55% | ₹10.00 Cr |
| 22 | EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC - EDELWEISS EQUITY SAVINGS FUND | 92,934 | 2.66% | ₹7.50 Cr |
| 23 | EDELWEISS TRUSTEESHIP CO LTD AC - EDELWEISS MF AC- EDELWEISS RECENTLY LISTED IPO FUND | 30,996 | 0.89% | ₹2.50 Cr |
| 24 | HDFC LIFE INSURANCE COMPANY LIMITED | 88,597 | 2.54% | ₹7.15 Cr |
| 25 | AXIS MAX LIFE INSURANCE LIMITED A/C SUSTAINABLE EQUITY FUND - ULIF02505/10/21SUSTAINEQU104 | 35,104 | 1.01% | ₹2.83 Cr |
| 26 | AXIS MAX LIFE INSURANCE LIMITED A/C - ULIF00225/06/04LIFEBALANC104 - BALANCED FUND | 33,367 | 0.96% | ₹2.69 Cr |
| 27 | AXIS MAX LIFE INSURANCE LIMITED PENSION MAXIMISER FUND (ULIF01715/02/13PENSMAXIMI104) | 11,401 | 0.33% | ₹0.92 Cr |
| 28 | AXIS MAX LIFE INSURANCE LIMITED A/C UHG2S - INDIA CONSUMPTION OPPORTUNITIES FUND | 2,625 | 0.08% | ₹0.21 Cr |
| 29 | AXIS MAX LIFE INSURANCE LIMITED A/C UMFPH - HIGH GROWTH PENSION FUND | 2,625 | 0.08% | ₹0.21 Cr |
| 30 | AXIS MAX LIFE INSURANCE LIMITED A/C - ULGF00217/04/06GRATBALANC104 -GROUP GRATUITY BALANCED FUND | 1,750 | 0.05% | ₹0.14 Cr |
| 31 | AXIS MAX LIFE INSURANCE LIMITED PENSION PRESERVER FUND(ULIF01815/02/13PENSPRESER104) | 862 | 0.02% | ₹0.07 Cr |
| 32 | AXIS MAX LIFE INSURANCE LIMITED A/C - ULIF00625/11/05PENSBALANC104 - PENSION BALANCED FUND | 862 | 0.02% | ₹0.07 Cr |
| 33 | BAJAJ LIFE INSURANCE LIMITED | 88,596 | 2.54% | ₹7.15 Cr |
Read from NSE's anchor allocation report · 2 d ago. Published only because the 33 rows reconcile exactly against the 34.88 L shares the filing itself declares.
Equity split
Fresh equity vs offer for sale- Fresh equity
- ₹200.00 Cr 21.3%
- Offer for sale
- ₹739.70 Cr 78.7%
- Total issue size
- ₹939.70 Cr
Read from the issue size stated in NSE's filing.
Objects of the issue
Where the fresh issue proceeds go- R&D facility, Centre of Excellence and office infrastructure₹105.50 Cr52.8%
- Plant, machinery and equipment for manufacturing units₹72.20 Cr36.1%
- General corporate purposes₹22.30 Cr11.2%
These add up to ₹200.00 Cr, the whole of the fresh issue. Only the fresh issue has objects — money raised in an offer for sale goes to the selling shareholders and never reaches the company. Compiled from the offer document by Zerodha; the prospectus is the authoritative version.
News about this IPO
All IPO news →Allotment status
Basis of allotment 13 Aug 2026You will need your PAN, application number or DP/client ID. These links go to the registrar and exchanges directly — UpcomingIPO never asks for those details.
Issue details
- Price band
- ₹768 – ₹807
- Lot size
- 18 shares
- Min. bid quantity
- 18
- Face value
- ₹1.00
- Tick size
- ₹1.00
- Shares offered
- 81.59 L
- Issue size
- ₹658.39 Cr
- Max bid · QIB
- 81.38 L
- Max bid · NII
- 58.13 L
- Employee discount
- Employee Discount of Rs 76 to Eligible Employees
Timeline & process
- Bidding opens
- 10 Aug 2026
- Bidding closes
- 12 Aug 2026
- Bidding hours
- 10.00 am to 5.00 pm
- UPI mandate cutoff
- 12-August-2026 (Upto 5.00 pm)
- Allotment
- 13 Aug 2026
- Listing
- 17 Aug 2026
Intermediaries
- Registrar
- KFin Technologies Limited
- Sponsor bank
- AXIS BANK
- Lead managers
- Kotak Mahindra Capital Company Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited), Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited